Publication:
Registry of the Spanish Network for Systemic Sclerosis: Survival, Prognostic Factors, and Causes of Death.

dc.contributor.authorSimeón-Aznar, C P
dc.contributor.authorFonollosa-Plá, V
dc.contributor.authorTolosa-Vilella, Carles
dc.contributor.authorEspinosa-Garriga, G
dc.contributor.authorCampillo-Grau, M
dc.contributor.authorRamos-Casals, M
dc.contributor.authorGarcía-Hernández, F J
dc.contributor.authorCastillo-Palma, M J
dc.contributor.authorSánchez-Román, J
dc.contributor.authorCallejas-Rubio, J L
dc.contributor.authorOrtego-Centeno, N
dc.contributor.authorEgurbide-Arberas, M V
dc.contributor.authorTrapiellla-Martínez, L
dc.contributor.authorCaminal-Montero, L
dc.contributor.authorSáez-Comet, L
dc.contributor.authorVelilla-Marco, J
dc.contributor.authorCamps-García, M T
dc.contributor.authorde Ramón-Garrido, E
dc.contributor.authorEsteban-Marcos, E M
dc.contributor.authorPallarés-Ferreres, L
dc.contributor.authorNavarrete-Navarrete, N
dc.contributor.authorVargas-Hitos, J A
dc.contributor.authorGómez de la Torre, R
dc.contributor.authorSalvador-Cervello, G
dc.contributor.authorRios-Blanco, J J
dc.contributor.authorVilardell-Tarrés, M
dc.contributor.authoraffiliation[Simeón-Aznar,CP; Fonollosa-Plá,V; Vilardell-Tarrés,M] Department of Internal Medicine, Hospital Valld’Hebron. [Tolosa-Vilella,C] Department of Internal Medicine, Hospital Parc Taulí, Sabadell. [Espinosa-Garriga,G; Campillo-Grau,M] Department of Autoimmune Diseases, Hospital Clinic. [Campillo-Grau,M] Laboratori of Computacional Medicine, Bioestatistics Unit, Universitat Autònoma de Barcelona, Bellaterra, Barcelona. [García-Hernández,FJ;Castillo-Palma,MJ; Sánchez-Román,J] Unit of Connective Tissue Diseases, Department of Internal Medicine, Hospital Virgen del Rocio, Sevilla. [Callejas-Rubio,JL; Ortego-Centeno,N] Unit of Autoimmune Systemic Diseases, Department of Internal Medicine, Hospital Clínico San Cecilio, Granada. [Egurbide-Arberas,MV] Department of Internal Medicine, Hospital de Cruces, Galdakano, Bilbao. [Trapiellla-Martínez,L] Department of Internal Medicine, Hospital de Cabueñes, Gijón. [Caminal-Montero,L] Department of Internal Medicine, Hospital Universitario Central de Asturias, Oviedo. [Sáez-Comet,L; Velilla-Marco,J] Department of Internal Medicine, Hospital Miguel Servet, Zaragoza. [Camps-García,MT; de Ramón-Garrido,E] Department of Internal Medicine, Hospital Carlos Haya, Málaga. [Esteban-Marcos,EM; Pallarés-Ferreres,L]Department of Internal Medicine, Hospital Son Espases, Palma de Mallorca. [Navarrete-Navarrete,N; Vargas-Hitos,JA] Department of Internal Medicine, Hospital Virgen de las Nieves, Granada. [Gómez de la Torre,R] Department of Internal Medicine, Hospital San Agustín, Avilés. [Salvador-Cervello,G] Department of Internal Medicine, Hospital La Fe, Valencia. [Rios-Blanco,JJ] Department of Internal Medicine, Hospital La Paz, Madrid
dc.contributor.groupSystemic Autoimmune Diseases Group (GEAS), Spanish Scleroderma Study Group (SSSG), Spanish Society of Internal Medicine, Spaines_ES
dc.date.accessioned2017-04-06T09:05:51Z
dc.date.available2017-04-06T09:05:51Z
dc.date.issued2015-10-30
dc.description.abstractSystemic sclerosis (SSc) is a rare, multisystem disease showing a large individual variability in disease progression and prognosis. In the present study, we assess survival, causes of death, and risk factors of mortality in a large series of Spanish SSc patients. Consecutive SSc patients fulfilling criteria of the classification by LeRoy were recruited in the survey. Kaplan-Meier and Cox proportional-hazards models were used to analyze survival and to identify predictors of mortality. Among 879 consecutive patients, 138 (15.7%) deaths were registered. Seventy-six out of 138 (55%) deceased patients were due to causes attributed to SSc, and pulmonary hypertension (PH) was the leading cause in 23 (16.6%) patients. Survival rates were 96%, 93%, 83%, and 73% at 5, 10, 20, and 30 years after the first symptom, respectively. Survival rates for diffuse cutaneous SSc (dcSSc) and limited cutaneous SSc were 91%, 86%, 64%, and 39%; and 97%, 95%, 85%, and 81% at 5, 10, 20, and 30 years, respectively (log-rank: 67.63, P < 0.0001). The dcSSc subset, male sex, age at disease onset older than 65 years, digital ulcers, interstitial lung disease (ILD), PH, heart involvement, scleroderma renal crisis (SRC), presence of antitopoisomerase I and absence of anticentromere antibodies, and active capillaroscopic pattern showed reduced survival rate. In a multivariate analysis, older age at disease onset, dcSSc, ILD, PH, and SRC were independent risk factors for mortality. In the present study involving a large cohort of SSc patients, a high prevalence of disease-related causes of death was demonstrated. Older age at disease onset, dcSSc, ILD, PH, and SRC were identified as independent prognostic factorses_ES
dc.description.versionYeses_ES
dc.identifier.citationSimeón-Aznar CP, Fonollosa-Plá V, Tolosa-Vilella C, Espinosa-Garriga G, Campillo-Grau M, Ramos-Casals M, et al. Registry of the Spanish Network for Systemic Sclerosis: Survival, Prognostic Factors, and Causes of Death. Medicine (Baltimore). 2015 ; 94(43):e1728es_ES
dc.identifier.doi10.1097/MD.0000000000001728es_ES
dc.identifier.essn1536-5964
dc.identifier.issn0025-7974
dc.identifier.pmcPMC4985378
dc.identifier.pmid26512564es_ES
dc.identifier.urihttp://hdl.handle.net/10668/2607
dc.journal.titleMedicine
dc.language.isoen
dc.publisherLippincott, Williams & Wilkinses_ES
dc.relation.publisherversionhttp://journals.lww.com/md-journal/Fulltext/2015/10270/Registry_of_the_Spanish_Network_for_Systemic.19.aspxes_ES
dc.rights.accessRightsopen access
dc.subjectSíndrome CRESTes_ES
dc.subjectCausas de muertees_ES
dc.subjectProgresión de la enfermedades_ES
dc.subjectHumanoses_ES
dc.subjectHipertensión pulmonares_ES
dc.subjectEnfermedades pulmonares Intersticialeses_ES
dc.subjectMasculinoes_ES
dc.subjectAnálisis multivariantees_ES
dc.subjectPrevalenciaes_ES
dc.subjectPronósticoes_ES
dc.subjectModelos de riesgos proporcionaleses_ES
dc.subjectFactores de riesgoes_ES
dc.subjectEsclerodermia difusaes_ES
dc.subjectEsclerodermia limitadaes_ES
dc.subjectEncuestas y cuestionarioses_ES
dc.subjectTasa de supervivenciaes_ES
dc.subjectÚlceraes_ES
dc.subjectEspañaes_ES
dc.subject.meshMedical Subject Headings::Diseases::Skin and Connective Tissue Diseases::Connective Tissue Diseases::Scleroderma, Systemic::Scleroderma, Limited::CREST Syndromees_ES
dc.subject.meshMedical Subject Headings::Analytical, Diagnostic and Therapeutic Techniques and Equipment::Investigative Techniques::Epidemiologic Methods::Data Collection::Vital Statistics::Mortality::Cause of Deathes_ES
dc.subject.meshMedical Subject Headings::Diseases::Pathological Conditions, Signs and Symptoms::Pathologic Processes::Disease Attributes::Disease Progressiones_ES
dc.subject.meshMedical Subject Headings::Organisms::Eukaryota::Animals::Chordata::Vertebrates::Mammals::Primates::Haplorhini::Catarrhini::Hominidae::Humanses_ES
dc.subject.meshMedical Subject Headings::Diseases::Respiratory Tract Diseases::Lung Diseases::Hypertension, Pulmonaryes_ES
dc.subject.meshMedical Subject Headings::Diseases::Respiratory Tract Diseases::Lung Diseases::Lung Diseases, Interstitiales_ES
dc.subject.meshMedical Subject Headings::Check Tags::Malees_ES
dc.subject.meshMedical Subject Headings::Analytical, Diagnostic and Therapeutic Techniques and Equipment::Investigative Techniques::Epidemiologic Methods::Statistics as Topic::Analysis of Variance::Multivariate Analysises_ES
dc.subject.meshMedical Subject Headings::Analytical, Diagnostic and Therapeutic Techniques and Equipment::Investigative Techniques::Epidemiologic Methods::Data Collection::Vital Statistics::Morbidity::Prevalencees_ES
dc.subject.meshMedical Subject Headings::Analytical, Diagnostic and Therapeutic Techniques and Equipment::Diagnosis::Prognosises_ES
dc.subject.meshMedical Subject Headings::Analytical, Diagnostic and Therapeutic Techniques and Equipment::Investigative Techniques::Epidemiologic Methods::Statistics as Topic::Models, Statistical::Proportional Hazards Modelses_ES
dc.subject.meshMedical Subject Headings::Analytical, Diagnostic and Therapeutic Techniques and Equipment::Investigative Techniques::Epidemiologic Methods::Statistics as Topic::Probability::Risk::Risk Factorses_ES
dc.subject.meshMedical Subject Headings::Diseases::Skin and Connective Tissue Diseases::Connective Tissue Diseases::Scleroderma, Systemic::Scleroderma, Diffusees_ES
dc.subject.meshMedical Subject Headings::Diseases::Skin and Connective Tissue Diseases::Connective Tissue Diseases::Scleroderma, Systemic::Scleroderma, Limitedes_ES
dc.subject.meshMedical Subject Headings::Diseases::Skin and Connective Tissue Diseases::Connective Tissue Diseases::Scleroderma, Systemices_ES
dc.subject.meshMedical Subject Headings::Analytical, Diagnostic and Therapeutic Techniques and Equipment::Investigative Techniques::Epidemiologic Methods::Data Collection::Questionnaireses_ES
dc.subject.meshMedical Subject Headings::Analytical, Diagnostic and Therapeutic Techniques and Equipment::Investigative Techniques::Epidemiologic Methods::Data Collection::Vital Statistics::Mortality::Survival Ratees_ES
dc.subject.meshMedical Subject Headings::Diseases::Pathological Conditions, Signs and Symptoms::Pathologic Processes::Ulceres_ES
dc.subject.meshMedical Subject Headings::Geographical Locations::Geographic Locations::Europe::Spaines_ES
dc.titleRegistry of the Spanish Network for Systemic Sclerosis: Survival, Prognostic Factors, and Causes of Death.es_ES
dc.typeresearch article
dc.type.hasVersionVoR
dspace.entity.typePublication

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
SimeonAznar_RegistryOTheSpanishNetwork.pdf
Size:
477.16 KB
Format:
Adobe Portable Document Format
Description:
Artículo publicado